Intervention not reported
Health‐related quality of life · participants with CTEV (type of case (i.e. whether initial presentation or relapsed) not specified)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events · participants with CTEV (type of case (i.e. whether initial presentation or relapsed) not specified)
1 finding from 1 review
no estimate extracted
1 study · 5 participants
Low
Intervention not reported
Gait assessment · participants with CTEV at initial presentation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Health‐related quality of life · participants with CTEV at initial presentation
1 finding from 1 review
Intervention not reported
Adverse events · participants with CTEV at initial presentation
The intervention may leads to lower adverse events (low certainty).
1 finding from 1 review
Intervention not reported
Function · participants with resistant CTEV
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Foot alignment · participants with resistant CTEV
1 finding from 1 review
Intervention not reported
Gait assessment · participants with resistant CTEV
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Health‐related quality of life · participants with resistant CTEV
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improvement of quality of life · people with mycosis fungoides
The review found no eligible studies for this question.
1 finding from 1 review
Common adverse effects ‐ Photosensitivity (Time point of measurement: up to 16 weeks) · people with mycosis fungoides
Bexarotene + PUVA showed no clear difference in common adverse effects ‐ Photosensitivity (Time point of… compared with PUVA alone (low certainty).
1 finding from 1 review
Complete response · people with mycosis fungoides
Bexarotene + PUVA showed no clear difference in complete response (Time point of measurement: up to 16 weeks) compared with PUVA alone (low certainty).
1 finding from 1 review
Objective response rate · people with mycosis fungoides
Bexarotene + PUVA showed no clear difference in objective response rate (Time point of measurement: up to 16 weeks) compared with PUVA alone (low certainty).
1 finding from 1 review
Improvement of quality of life · people with mycosis fungoides
The review found no eligible studies for this question.
1 finding from 1 review
Adverse event (flu‐like symptoms) · people with mycosis fungoides
IFN‐α + acitretin showed no clear difference in common adverse effects ‐ Flu‐like symptoms (Time point of… compared with IFN‐α + PUVA (low certainty).
1 finding from 1 review
Complete response · people with mycosis fungoides
IFN‐α + acitretin may leads to lower complete response (Time point of measurement: up to 48 weeks or… compared with IFN‐α + PUVA (low certainty).
1 finding from 1 review
Objective response rate · people with mycosis fungoides
The review found no eligible studies for this question.
1 finding from 1 review
Improvement of quality of life · people with mycosis fungoides
1 finding from 1 review
Common adverse effects · people with mycosis fungoides
1 finding from 1 review
Complete response · people with mycosis fungoides
1 finding from 1 review